And how do we pick who gains and who loses?

Mark Sculpher

Monday, March 25 2019 at 7:30PM

Download iCalendar file
(e.g. import to Outlook or Google Calendar)


75 George St

Mark Sculpher

What's the talk about?

The NHS is not the only health care system in the world that struggles to meet the demands placed on it by an ageing population and the growing availability of treatments.  No system has access to infinite resources, so the challenge is to establish an acceptable way to judging between the claims to health care of different groups of patients.  This is particularly the case when assessing whether new pharmaceuticals should be made available, and at what price they are affordable.  The talk will suggest a set of principles by which such decisions can be taken, focussing on the importance of evidence regarding the additional health benefits offered by new treatments, but also their additional costs and what these imply regarding the health benefits that other types of patients will not enjoy if the treatment is funded.  The extent to which these principles are followed by organisations like the National Institute for Health and Care Excellence (NICE) will be considered, and the implications for the health of the population of their not doing so assessed.

Mark Sculpher is Professor of Health Economics at the Centre for Health Economics, University of York.  He will discuss how his research in this area has (and has not) been used to guide NHS policy in this challenging area.